Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe they can't have patents for an illegal drug just yet. It may put them under the radar for a raid. Hopefully they know what their doing as it has been really quiet. I just want this month to be over. Hoping 2012 is our breakout. I can't imagine the price going any lower as the longs here want to exercise their warrents.
I've been using e cigs for about a year now. Love them. I'll be so pissed if they determine them to be more dangerous than cigarettes.
Does anyone know how many patents CBIS has?
phew! I got nervous there for a second. That makes perfect sense. Thanks
Sorry can you briefly explain what A/S stands for?
It might be the right time to double my bet.
hahaha I feel like I'm at the casino and the dealer just hit black jack 4 times in a row.
It's so quiet I could hear a pin drop. Calm before the storm? News coming? Massive volume trading Friday. Starting to squeeze.
Lostcoast. I know you bought shares just after I did. Just stick in there man. I know we are down but we are not out. I feel that there are a lot of good things coming for this. I'd say hold out and see where we are in 6 months. All it's going to take is some wealthy doctors or a pharmacutical company to get involved. Be patient my friend.
I'm trying to stay positive. At this rate the new share class will be coming out at .45 cents a share following the 30/1 conversion rate. This has been one hell of a perfect storm. I feel that our ship is at the top of the arc of a sunami wave. I hope this CBIS submarine can over it and move on the the "promise land" or the "new world".
If I wasn't middle class I'd be throwing big ben's all over this stock then laughing all the way to the bank in about 5 years.
Upstate NY Represent
Damn really hoping that order didn't fill already. It's gone now.
Wow 1 million shares at bid right now that's the largest I've ever seen.
It could just be the shorts losing their shares. They have been manipulating the price for months now. Happy to see some heavy buys. Hopefully whoever is making those purchases is going to hold.
I'm starting to get excited here. Lots of good things in the works.
Us longs just have to man up and buy the shares. We gotta buy them out so we can control the price.
Damn there is a lot of shares for sale at .019.
News Article from Yahoo is below about the Governers. Sure would be nice to get a call in to this reporter and provide some clairty coming from CBIS and their new market in Colorado. Information on the products and the diseases that treat.
OLYMPIA, Wash. (AP) — Washington Gov. Chris Gregoire and Rhode Island Gov. Lincoln Chafee have filed a petition with the U.S. Drug Enforcement Administration asking the agency to reclassify marijuana so doctors can prescribe it and pharmacists can fill the prescription.
The governors said Wednesday they want the federal government to list marijuana as a Schedule 2 drug, allowing it to be used for medical treatment. Marijuana is currently classified a Schedule 1 drug, meaning it's not accepted for medical treatment and can't be prescribed, administered or dispensed.
Washington and Rhode Island are two of 16 states, and the District of Columbia, that have laws allowing the medical use of marijuana.
"Each of these jurisdictions is struggling with managing safe access to medical cannabis for patients with serious medical conditions," the 99-page petition and report reads. "Our work with the federal agencies has not resolved the matter."
Gregoire said that the conflict between state and federal laws means legitimate patients lack a regulated and safe system to obtain marijuana.
"It is time to show compassion and time to show common sense," she said in a conference call with reporters Wednesday.
Washington voters approved a medical marijuana law in 1998 that gives doctors the right to recommend — but not prescribe — marijuana for people suffering from cancer and other conditions that cause "intractable pain."
Earlier this year, Gregoire vetoed most of a bill that made major reforms to the state's medical marijuana law, saying state workers could be prosecuted under federal law the way the measure was written.
The legislation was passed to set clearer regulations on medical marijuana use and to establish a licensing system and patient registry to protect qualifying patients, doctors and providers from criminal liability. Gregoire vetoed provisions of the bill that would have licensed and regulated medical marijuana dispensaries and producers. She also nixed a provision for a patient registry under the Department of Health.
"There's chaos and conflict between what the states are doing and what the Justice Department is threatening to do," said Chafee, who was on Wednesday's conference call with Gregoire.
A DEA spokeswoman said officials at the agency had heard of the petition but could not comment.
Earlier this month, the DEA raided 10 storefront dispensaries in Washington state, including several in Seattle, where law enforcement officials have taken a lenient view of medical marijuana grows and dispensaries. Search warrant affidavits suggested the shops were fronts for illicit drug dealing and revealed that agents were looking for evidence of drug conspiracies, money laundering and guns. Similar raids occurred in Montana and California as well.
Morgan Fox of the Washington, D.C.-based Marijuana Policy Project said the petition was a "good first step" but reclassifying the drug will not "change the federal penalties for possessing, cultivating or distributing medical marijuana."
"That is the change we really need," Fox said in a news release. "These governors should be insisting that the federal government allow them to run their medical marijuana operations the ways they see fit, which in these cases includes allowing regulated distribution centers to provide patients with safe access to their medicine and not force them to turn to illicit dealers."
The DEA has rejected prior petitions seeking to reclassify marijuana, but Gregoire noted that this is the first petition signed by governors.
Gregoire also said the science on the issue has changed. The American Medical Association reversed its position two years ago and now supports investigation and clinical research of cannabis for medicinal use.
Gregoire said she was on a phone call in August with other governors in medical marijuana states and said that there was a "huge volume" of interest.
Asked why no other governors have signed onto the initial petition, Gregoire said she and Chafee wanted to take the lead on the initiative.
"I have every expectation that you will see other governors join us," she said.
Vermont Gov. Peter Shumlin plans to sign the petition and write a letter in support of the proposed change, said spokeswoman Susan Allen. Gil Duran, a spokesman for California Gov. Jerry Brown, did not have an immediate comment when asked about the petition Wednesday.
"The governors in Washington and Rhode Island raise a valid conflict that needs to be resolved," said Eric Brown, a spokesman for Colorado Gov. John Hickenlooper. "Colorado law requires we make a similar ask of the federal government by Jan. 1. We will do that. We will also continue to consult with other governors on this issue and with Colorado's attorney general before deciding whether anything else will be done."
Other governors did not immediately respond to requests from The Associated Press.
There is currently an effort in Washington state to decriminalize and tax recreational marijuana sales for adults. Initiative 502, which has been endorsed by two former Seattle U.S. attorneys and the former head of the FBI in Washington state, would create a system of state-licensed growers, processors and stores, and would impose a 25 percent excise tax at each stage. Adults 21 and over could buy up to an ounce of dried marijuana; one pound of marijuana-infused product in solid form, such as brownies; or 72 ounces of marijuana-infused liquids. It would be illegal to drive with more than 5 nanograms of THC, the active ingredient of cannabis, per milliliter of blood.
Sponsors need to collect more than 240,000 valid signatures by Dec. 30 to place the measure before the Legislature early next year. If the Legislature doesn't take up the issue, it automatically goes to the November ballot.
When asked about the initiative, Gregoire said her focus was on medical marijuana, and how to "get relief that is safe and readily available to these patients."
___
Rachel La Corte can be reached at http://twitter.com/RachelAPOly . Associated Press writers Juliet Williams in Sacramento, Calif., Dave Gram in Montpelier, Vt., and Kristen Wyatt in Denver contributed to this report.
That would be a dream come true. There should be some sort of benefit to shareholders that are over 50% down in the stock. Unfortunatly I started buying in March of this year.
I don't really give a fluff. I'm holding on to this one. Hopefully this golden goose will lay an egg soon.
Drug Shortages are becoming a reality. Open the door to Medical Marijuana.
Check out this video.
http://www.pressconnects.com/videonetwork/1300655154001?odyssey=mod|tvideo|article
How many shares need to be bought to knock out the shorts? Any one have an idea?
I'm thinking 250,000 shares. Who's in? It would be beneficial for us future longs to buy them all and sell them back on small levels to increase share price.
The 10Q is pretty depressing to look at. By the looks of it, CBIS has been taking a beating and is close to sinking. I have faith that this year will either make or bust CBIS. By the looks of things I'm thinking it will be a make. Everything is starting to align for sucess.
I love the PR today ! Great References. This is looking to be real good in the near future. I'm buying more.
Will their be any benefit to shareholders who purchased CBIS in 2011? Part of me feels I missed the boat here, however I'm just hoping that the class B shares will still continue to prosper even after the other two classes are created. Any insight on this?
Congrats longs. Nice pay off for you here being this is down about over 50%. Stock was worth .05 12/31/10
It was valued over $1 at one point in time.
Congratulations Longs! You all deserve it as you've all been holding on by the tips of your finger nails. I'm not a long here but I'm excited to see that CBIS is following through on everything. It's nice to put the critics in their place.
The future looks good.
The report looks good. I'm starting to get excited.
Mistra l Ventures and Cannabis Sciences - Unique Routes to Success
8:16 AM ET 11/15/11 | Marketwire
While traditional biotech companies typically have to struggle through several years, and millions of dollars, before possibly reaching FDA approval, natural supplements can have a far easier time reaching the market. In recent years the supplement market has skyrocketed, while the traditional synthetic biotech industry has battled with a stricter FDA approval system. The Paragon Report examines investing opportunities in the Healthcare Sector and provides equity research on Mistral Ventures, Inc. (PINKSHEETS: MILV) and Cannabis Sciences, Inc. (OTCBB: CBIS). Access to the full company reports can be found at:
www.paragonreport.com/MILV
www.paragonreport.com/CBIS
Some lawmakers in Washington have been arguing that the FDA's tougher safety stance has slowed down the pace of drug approvals and is hurting the pharmaceutical and biotech industry. According to Krishan Maggon, a Geneva-based pharmaceuticals consultant, the number of new biotech drugs approved in the U.S. has remained in the 20 to 25 range during the past four years, while in Europe the figure was a record-low 14 last year.
Janet Woodcock, the head of the FDA's drug division, defended the FDA's role, saying challenges being faced by the biotech and pharmaceutical industry are related to high failure rates of drugs in the development process rather than FDA regulations.
The Paragon Report provides investors with an excellent first step in their due diligence by providing daily trading ideas, and consolidating the public information available on them. For more investment research on the Healthcare Sector register with us free at www.paragonreport.com and get exclusive access to our numerous stock reports and industry newsletters
Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures, says that its line of natural medicines will be either sold as prescription drugs, if applied for by the company and approved by the FDA, or sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994. Last week the company announced that it is finalizing arrangements to commence production of its Breathing Relief Formula. Robert deZanger, CEO of Nature's Bioceuticals went as far as to say the company "anticipate sales in excess of $10,000,000.00 the first year and then expanding and exponentially thereafter."
Cannabis Science Inc. is a development stage company engaged in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. It primarily focuses on developing medications to treat autism, blood pressure, cancer and cancer side effects, HIV, and other illnesses, including general health maintenance.
The Paragon Report has not been compensated by any of the above-mentioned publicly traded companies. Paragon Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at http://www.paragonreport.com/disclaimer
SOURCE: Paragon Financial Limited
That's awesome. I just hope that it is 100% professionaly done. They always show both sides of the story. Hopefully curing skin cancer and so many other diseases will prevail.
Love it Gooch. Thanks for the info. Go Kane9 ! Thank you CBIS for the cures you have provided to mankind.
Newmedman and CatPuke! Where are ya brothas?
245,000 on the sell. I hate you fluckin short scum bags. Just stopped the run dead in its tracks. I'm not selling anything but it sure would be nice to see this get back to .03
I really can't wait to see where this stock is 6 months from now. I think it's going to be huge.
This is great news. Good work CBIS. Time to start getting some exposure.
Cannabis Science Prepares Release of Second Cannabis-Extract-Based Formulation Along with Official Facebook and Twitter Page
A1:47 PM ET 11/9/11 | BusinessWire
Cannabis Science, Inc. (OTCBB:CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce the preparation to release of the second Cannabis Science brand formulation. The Company has been receiving a constant flow of inquires via its website, emails, and telephone calls for cannabis-extract based medicines. For example, cancer patients seeking extract-based formulations for topical or internal use have frequently contacted Cannabis Science. Manufacturing and packaging is being completed for release through Colorado state licensed dispensaries.
In light of the accumulating anecdotal reports of the successful cancer treatments with cannabis extracts, the Company will continue to keep patients updated on current peer-reviewed scientific literature supporting the historical and modern use of cannabis to treat "tumors". Unlike conventional treatment, cannabis medicines have an outstanding safety profile allowing patients in states with medical marijuana laws to safely make informed decisions to legally self-administration of various cannabis-based preparations.
The second Cannabis Science Brand extract-based formulation is comprised of high quality extracts packaged in oral dispensing syringes for patient self-administration for treatment. This is a critical milestone for the Company in bringing its second formulation to market. Other formulations will be made available soon to medical marijuana patients in Colorado and other legal medical marijuana states, such as California through select California State licensed dispensaries. The Company's intent is to work with specially appointed legal providers and laboratories to expand the availability of its formulations across the United States where legally available.
Dr. Robert Melamede, Ph.D., the Company's CEO, said, "We hear from so many people wanting a reliable, high-quality formulation that they can self-administer to treat a wide variety ailments. A quality, standardized formulation is essential for long term care. Initially, we have chosen two State licensed facilities in Colorado to work with, both of the facilities were chosen for the quality of their botanicals and patient care. We are looking forward to expanding availability to other facilities in legal medical marijuana States, specifically California, along with an increased multiple formulation offerings."
Social Network
Please visit http://www.facebook.com/pages/Cannabis-Science/216643278395932
Please visit http://twitter.com/#!/CannabisScienc1
At the same time Cannabis Science is proud to announce the release of their social network pages on Facebook and Twitter.
Facebook has over 250 million global users and over 600 million visitors half of which visit more than once a day.* Twitter has over 175 million* and has become a powerful media and marketing resource especially for a global company like Cannabis Science.
In reference to the social networks Dr. Robert Melamede said "One of our current goals at Cannabis Science is to increase communication and exposure on a global scale of the Cannabis Science mission to alleviate suffering and promote health through cannabinoid science. Facebook and Twitter are not only the resource but the catalyst."
Dr. Melamede continued, "Cannabis Science Facebook and Twitter pages are an information resource in regards to the company and their operations. There will be updates on our first and second cannabis-extract-based formulations. More importantly, these pages will document how Cannabis Science is moving forward. Patients, medical professionals and all those interested in the scientific side of the medical cannabis industry can follow us and be included in the global conversation. We hope this conversation includes testimonials of people successes, tracks different patients ideas and possible product releases for different ailments. The ultimate goal of these Facebook and Twitter sites is to be a call to the world that includes discussion from patients and to have this conversation mature into a support campaign for the FDA."
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
*Source Twitter API page, Business Insider, March 31, 2011 Nicholas Carlson
SOURCE: Cannabis Science, Inc.
Cannabis Science Inc.
Dr. Robert J. Melamede, 1-888-889-0888
President & CEO
or
Robert Kane
Investor Relations Management
1-561-234-6929
info@cannabisscience.com
www.cannabisscience.com
What in the world is going on here??? Where did everyone go? I cannot believe we are flirting with 1's right now.
If this really goes down tomorrow I expect a huge boost to the Medical Marijuna sector. Looking forward to Monday. Wish I had more money to buy more at this price.
Can't let them get you down. Nothing is built overnight. This is a stock to just put in your pocket. If it helps don't follow it so closely. It's just a matter of time in my opinion. Even if it does go to 10 cents I'm still not selling.
I'm waiting for Bigger and Better news before I sell.
I really hope CBIS doesn't become quiet now after delivering the product. I want to see some news about the international market. What is going on in Thailand? Any other contracts to disclose?
What is going on with CBIS's other products?
Big sale of over 200,000 shares = $5,500 right now. I guess someone wants to miss the boat here??? Nice Short Shorts
Yeah Buddy!!! Can't wait for this to get some attention from some major broadcasters. It's just a matter of time. So many people out there don't realize that CBIS has a cure to cancer and so many other common diseases.